Work

Enhancing dendritic cells by inhibiting BCL2

Year: 2023

Type: article

Source: Trends in cancer

DOI: 10.1016/j.trecan.2023.09.007

Authors: Christopher A.G. Booth, Andrew A. Lane

Institutions: Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Leukemia and Lymphoma Society

OpenAlex ID: W4387217893

FWCI: 0.178

Cites: 10

Cited by: 2

Related to: 10